Michael Lehrke

Resistin Is an Inflammatory Marker of Atherosclerosis in Humans

Muredach P. Reilly, Michael Lehrke, Megan L. Wolfe et al. · Circulation · 2005 · 904 citations · Full text

Veterinary Medicine, Cardiology, Physiology +15

Reversal of Nonalcoholic Hepatic Steatosis, Hepatic Insulin Resistance, and Hyperglycemia by Moderate Weight Reduction in Patients With Type 2 Diabetes

Kitt Falk Petersen, Sylvie Dufour, Douglas E. Befroy et al. · Diabetes · 2005 · 898 citations · Full text

Medicine, Endocrinology, Nutrition +17

High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers.

Stefan Walenta, Michael Wetterling, Michael Lehrke et al. · PubMed · 2000 · 827 citations

Medicine, Cancer Biology, Oncology +17

Empagliflozin Increases Cardiac Energy Production in Diabetes

Subodh Verma, Sonia Rawat, Kim L. Ho et al. · JACC Basic to Translational Science · 2018 · 376 citations · Full text

Life Sciences, Cardiology, Pharmacology +17

Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis

Michael Lehrke, Alexander Becker, Martin Greif et al. · European Journal of Endocrinology · 2009 · 297 citations

Medicine, Biochemistry, Cardiology +17